Clinical utility and limitations of FDG PET in detecting recurrent hepatocellular carcinoma in postoperative patients

The clinical usefulness of positron emission tomography (PET) with 18F-fluorodeoxyglucose (FDG) for the detection of recurrent hepatocellular carcinoma (HCC) is controversial because HCC displays varying FDG avidity. The purposes of this study were to re-evaluate the utility of FDG PET for the detection of recurrent HCC, and to assess its prognostic value in a large series of postoperative patients. We retrospectively reviewed 113 scans in 86...